Please assess the completion status of the following clinical trial:

Trial Title: Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Children and adolescent suffering from type 1 Diabetes Mellitus, for at least 3 years from the onset of the disease.~Exclusion Criteria:~* Children with Congenital Heart Diseases.~* Children with acquired cardiac diseases.~* Children with other systemic diseases.~* Symptomatic diabetic cardiomyopathy.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- diabetic- no cardioprotectives (Type: NO_INTERVENTION): 25 child with type 1 diabetes mellitus will not receive any cardio protective drug
- diabetic-Atorvastatin (Type: EXPERIMENTAL): 25 child with type 1 diabetes mellitus will receive Statin (2 mg/kg/day)
- diabetic-Captopril (Type: EXPERIMENTAL): 25 child with type 1 diabetes mellitus will receive Captopril (0.2 mg/kg/day)
- diabetic-L-Carnitine (Type: EXPERIMENTAL): 25 child with type 1 diabetes mellitus will receive L-carnitine (50 mg/kg/day)
- Controls (Type: NO_INTERVENTION): 50 healthy children, of matched age and sex, with no symptoms of cardiac diseases

Based on this trial design, predict the completion outcome and termination type (if applicable).